Identification and Monitoring of Host Cell Proteins by Mass Spectrometry Combined with High Performance Immunochemistry Testing

• Katrin Bomans,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Antje Lang,

  Affiliation Pharma Biotech, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Veronika Roedl,

  Affiliation Pharma Biotech, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Lisa Adolf,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Kyrillos Kyriosoglou,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Katharina Diepold,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Gabriele Eberl,

  Affiliation Pharma Biotech, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Michael Mølhøj,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Ulrike Strauss,

  Affiliation Pharma Biotech, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Christian Schmalz,

  Affiliation Pharma Biotech, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Rudolf Vogel,

  Affiliation Professional Diagnostics, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Dietmar Reusch,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Harald Wegele,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Michael Wiedmann,

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Patrick Bulau

  * E-mail: patrick.bulau@roche.com

  Affiliation Pharma Development, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯